| 10450288 |
Hydroxy formamide derivatives and their use |
Sarah E. Dowdell, Hilary Schenck Eidam, Mark ELBAN, Ryan Michael Fox, Mark A. Hilfiker +7 more |
2019-10-22 |
|
| 9487507 |
TRPV4 antagonists |
Carl Brooks, Mui Cheung, Hilary Schenck Eidam, Krista B. Goodman, Mark A. Hilfiker +3 more |
2016-11-08 |
|
| 9187464 |
TRPV4 antagonists |
Carl Brooks, Mui Cheung, Hilary Schenck Eidam, Krista B. Goodman, Mark A. Hilfiker +4 more |
2015-11-17 |
|
| 8927585 |
TRPV4 antagonists |
Carl Brooks, Mui Cheung, Krista B. Goodman |
2015-01-06 |
|
| 7358242 |
Tetraazabenzo[e]azulene derivatives and analogs thereof |
Richard L. Elliott, Kimberly O. Cameron |
2008-04-15 |
$190,443,000 |
| 7268133 |
Cannabinoid receptor ligands and uses thereof |
David A. Griffith |
2007-09-11 |
|
| 7265104 |
Tetraazabenzo[e]azulene derivatives and analogs thereof |
Richard L. Elliott, Kimberly O. Cameron |
2007-09-04 |
$133,000,000 |
| 7247628 |
Cannabinoid receptor ligands and uses thereof |
Robert L. Dow |
2007-07-24 |
$742,926,000 |
| 6958347 |
Aminophenanthridinone and aminophenanthridine as NPY-5 antagonists |
— |
2005-10-25 |
$229,343,000 |
| 6693199 |
Method of making HIV protease inhibitors |
Bruce A. Dressman, James E. Fritz, William J. Hornback, Stephen W. Kaldor, Vincent Jacob Kalish +5 more |
2004-02-17 |
|
| 6566367 |
Spiro[isobenzofuran-1,4′-piperidin]-3-ones and 3H-spiroisobenzofuran-1,4′-piperidines |
Rajagopal Bakthavatchalam, Charles A. Blum, Harry Brielmann, James Darrow, Stéphane De Lombaert +4 more |
2003-05-20 |
|
| 6525215 |
HIV protease inhibitors |
Bruce A. Dressman, James E. Fritz, William J. Hornback, Stephen W. Kaldor, Vincent Jacob Kalish +5 more |
2003-02-25 |
|
| 6515133 |
Pharmaceutical compositions containing certain diarylimidazole derivatives |
Andrew Thurkauf, Jun Yuan, Alan Hutchison, Charles A. Blum, Richard Elliott |
2003-02-04 |
|
| 6514966 |
Compounds for the treatment of obesity |
Richard L. Elliott, Richard F. Hank |
2003-02-04 |
$317,584,000 |
| 6407120 |
Neuropeptide Y antagonists |
Philip A. Carpino, Richard F. Hank |
2002-06-18 |
$368,716,000 |
| 6399631 |
Carbazole neuropeptide Y5 antagonists |
Richard L. Elliott, David A. Griffith |
2002-06-04 |
$269,922,000 |
| 6355635 |
Compounds for the treatment of obesity |
Richard L. Elliott, Richard F. Hank |
2002-03-12 |
$439,076,000 |
| 6197822 |
Neuropeptide antagonists |
— |
2001-03-06 |
$476,653,000 |
| 6187778 |
4-aminopyrrole (3, 2-D) pyrimidines as neuropeptide Y receptor antagonists |
Robert L. Dow |
2001-02-13 |
$616,695,000 |
| 6162812 |
Pharmaceutical compositions containing HIV protease inhibitors and methods of their use |
Bruce A. Dressman, James E. Fritz, William J. Hornback, Stephen W. Kaldor, Vincent Jacob Kalish +5 more |
2000-12-19 |
|
| 6121260 |
Method of treating conditions susceptible to modulation of NPY receptors with diarylimidazole derivatives |
Andrew Thurkauf, Jun Yuan, Alan Hutchison, Charles A. Blum, Richard L. Elliot |
2000-09-19 |
|
| 5834467 |
HIV protease inhibitors |
Vincent Jacob Kalish, Bruce A. Dressman, James E. Fritz, William J. Hornback, Stephen W. Kaldor +5 more |
1998-11-10 |
$18,517,000 |
| 5827891 |
HIV protease inhibtors |
Bruce A. Dressman, James E. Fritz, William J. Hornback, Stephen W. Kaldor, Vincent Jacob Kalish +5 more |
1998-10-27 |
$5,897,000 |
| 5821331 |
Anti-picornaviral agents |
Stephen W. Kaldor |
1998-10-13 |
$44,150,000 |
| 5719287 |
Intermediates for inhibitors of HIV protease and method of preparation thereof |
Stephen W. Kaldor |
1998-02-17 |
$104,522,000 |
